Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Preferred Stock Liabilities (2020 - 2021)

Celularity has reported Preferred Stock Liabilities over the past 2 years, most recently at $290.9 million for Q2 2021.

  • Quarterly results put Preferred Stock Liabilities at $290.9 million for Q2 2021, changed 0.09% from a year ago — trailing twelve months through Jun 2021 was $290.9 million (changed 0.09% YoY), and the annual figure for FY2020 was $184.2 million, changed.
  • Preferred Stock Liabilities for Q2 2021 was $290.9 million at Celularity, up from $75.0 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for CELU hit a ceiling of $290.9 million in Q2 2021 and a floor of $75.0 million in Q1 2020.